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Abstract
Background: Ambulatory wireless video electroencephalography (AEEG) is the
method of choice to discriminate epileptic seizures from other nonepileptic episodes.
However, the influence of prior general anesthesia (GA), sedation, or antiseizure drug
(ASD) on the diagnostic ability of AEEG is unknown.
Hypothesis/Objectives: The use of sedation/GA or ASD treatment before AEEG
recording may affect the diagnostic ability of AEEG and the time to first abnormality
on AEEG.
Animals: A total of 108 client-owned dogs undergoing ambulatory AEEG for paroxys-
mal episodes.
Methods: Retrospective cohort study. Proportions of diagnostic AEEG and time to
first abnormality were compared between dogs that received sedation/GA or neither
for instrumentation as well as dogs receiving at least 1 ASD and untreated dogs.
Results: Ambulatory EEG was diagnostic in 60.2% of all dogs including 49% of the
sedation/GA dogs and 68% of dogs that received neither (odds ratio [OR], 2.25; 95%
confidence interval [CI], 1.02-5.00; P = .05). The AEEG was diagnostic in 51% of dogs
receiving at least 1 ASD and 66% of untreated dogs (OR, 1.95; 95% CI, 0.9-4.3;
P = .11). No difference was found in time to first abnormality between sedation/GA
or neither or ASD-treated or untreated dogs (P = .1 and P = .3 respectively). Ninety-
five percent of dogs had at least 1 abnormality within 277 minutes.
Conclusion and Clinical Importance: Sedation/GA and concurrent ASD administra-
tion were not identified as confounding factors for decreasing AEEG diagnostic capa-
bility nor did they delay the time to first abnormality. A 4-hour minimal recording
period is recommended.
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1 | INTRODUCTION
Differentiating epileptic seizures from other paroxysmal episodes is
important in clinical practice to ensure that appropriate treatment is
started. Currently, the distinction mainly relies on clinical history and
videos of the episode, which have shown low interobserver agree-
ment on the presence or absence of an epileptic seizure and the
nature of the seizure.1 Recording the electrical activity of the brain by
electroencephalography (EEG) represents the most objective way of
differentiating an epileptic seizure from another paroxysmal epi-
sode.2-4 Although not all seizures present with abnormal electrical dis-
charges on EEG and some electrical discharges are not associated
with epilepsy, this test is the standard of care in human medicine for
investigation of paroxysmal disorders.4,5 Electroencephalography is
not commonly performed in veterinary medicine for several technical
reasons such as difficulty to place and maintain several functional
electrodes as well as the need for special training to interpret it with
ease. This impractical clinical application of EEG in veterinary medi-
cine partly may explain the lack of protocol standardization, which
makes it difficult to compare findings between different recordings.6-16
Nonetheless, EEG has proven useful in veterinary medicine to detect
epileptic activity that was not clinically observable.17,18 In recent
years, the use of ambulatory video EEG (AEEG) has been reported in
dogs.10 This procedure enables recording a patient's brain electrical
activity while allowing video capture of the paroxysmal episode. It
therefore potentially can increase the diagnostic yield of AEEG
because it does not rely solely on detection of interictal discharges
but also allows diagnosis of nonepileptic disorders if the AEEG
shows no abnormal discharges while the patient experiences an
episode.10 This technique however does not improve the practicality
of electrode placement and thus general anesthesia (GA) or sedation
commonly are used to place the electrodes before recording.
However, GA frequently is used to treat refractory status epilepticus
and therefore may have a suppressive effect on epileptic discharges.19
Some drugs used for sedation also may have some anti- or proepileptic
effects that could affect the diagnostic capability of AEEG.20-23 Simi-
larly, the fact that dogs often are started on an antiseizure drug (ASD)
before AEEG is performed may change the probability of recording
epileptic discharges on AEEG.24,25
Our objective was to evaluate the use of sedation/GA or ASD
treatment for electrode placement before recording as confounding
factors for not achieving a diagnosis on AEEG in dogs presenting for
paroxysmal episodes. We hypothesized that sedation/GA for elec-
trode placement or use of an ASD may change the probability of esta-
blishing a diagnosis on AEEG and may delay the time taken to observe
at least 1 abnormality or episode during the recording.
2 | MATERIALS AND METHODS
Medical records of dogs that underwent AEEG examination were
reviewed from 5 academic and private veterinary referral hospitals. All
AEEG were performed with owner consent during investigation of
paroxysmal episodes. Dogs were included if they had a history of par-
oxysmal episodes (suspected epileptic seizures or suspected non-
epileptiform episode, referred to as “episode of interest”) and had an
AEEG performed. Dogs for which the AEEG was uninterpretable
because of major artifacts were excluded from the study. Dogs that
underwent AEEG for status epilepticus monitoring or that were
obtunded or comatose because of a severe intracranial pathology
were excluded from this study because they would not have been
able to behave freely and show paroxysmal episodes. Dogs also were
excluded if there was no mention about having received sedation, GA,
or ASD in their record. For dogs that underwent multiple AEEG, only
the first recording for initial investigation of paroxysmal episodes was
analyzed. Breed, sex, age, abnormal episode frequency, and ASD
treatment at the time of recording were retrieved from the medical
records. A subset of these dogs was described in a previous study
evaluating the diagnostic capability of wireless AEEG but not evaluat-
ing the effect of sedation/GA and ASD on the diagnostic yield of
AEEG.10
Wireless AEEG with synchronized video was recorded using a
Trackit MK3 AEEG/Polygraphy recorder (Lifelines Neurodiagnostic
Systems, Troy, Illinois) according to a previously published protocol.10
Number of electrodes varied according to the size of the patient's
head with small patients having fewer electrodes placed.10 Because it
is an ambulatory system, dogs were awake and behaving as they
would normally during AEEG recording.
The AEEG recording duration was not standardized, and AEEG
recordings were ended when the patient removed the electrodes, epi-
sodes of interest were observed and allowed a diagnosis or when the
patient was discharged from the hospital. The AEEG was digitally
saved and reviewed retrospectively by 2 board-certified veterinary
neurologists who were not blinded to the nature of the episodes. A
subset of AEEG was reviewed by a pediatric neurophysiologist if a
conclusion on the diagnosis was not reached by the veterinary
neurologists.
The AEEG was classified as diagnostic either if it confirmed epi-
leptic seizures by showing ictal or interictal epileptiform discharges
(epileptic seizure) as defined previously,26 or if it recorded the episode
of interest on the synchronized video and showed no abnormal dis-
charge on AEEG during the episode (nonepileptiform paroxysmal epi-
sode). Ictal or interictal epileptiform discharges included single or
trains of focal or generalized spikes, sharp waves, spike waves, poly-
spikes, and polyspike waves.26 The AEEG was classified as non-
diagnostic if no episode and no abnormal ictal or interictal discharges
were recorded. Hence, a patient suspected to have experienced epi-
leptic seizures based on history and clinical assessment but that did
not show any episode or ictal or interictal epileptiform discharge dur-
ing AEEG was classified as having a nondiagnostic AEEG. Moreover,
the time to first abnormality was recorded as the duration of time
elapsed between the beginning of recording and the first epileptiform
discharge noted on AEEG or the first paroxysmal episode observed on
video.
To compare the effect of sedation and GA on diagnostic capabil-
ity of AEEG, patients were divided into 2 groups depending whether
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or not they had received any drugs for sedation/GA for electrode
placement before AEEG recording. Because many sedative drugs were
used before GA, dogs that received sedation and dogs that received
GA were grouped together. For dogs in the sedation/GA group, AEEG
was recorded long enough to allow recovery (return to ambulation)
from sedation/GA to ensure that part of the recordings was per-
formed on awake ambulatory dogs. To compare the effect of prior
ASD treatment on diagnostic capability, patients were allocated into 2
groups depending on whether or not they were receiving any ASD at
the time of AEEG recording.
Simple descriptive statistics were performed on the study pop-
ulation signalment, proportion of epileptic patients, time to first
abnormality, and duration of AEEG in each group. Continuous vari-
ables were evaluated for normality using the Shapiro-Wilk test and
examination of residuals. For normally distributed variables, Stu-
dent's t tests or analysis of variance (ANOVA) was used. For vari-
ables that were not normally distributed, a log-transformation was
applied before using a Student's t test or ANOVA. If the log-trans-
formed variables were not normally distributed, a nonparametric
Mann-Whitney U test was used. Proportions were compared using
Fisher's exact tests. Episode frequency was described as minutely,
hourly, daily, weekly, monthly, or annually and compared between
groups using a Cochran-Armitage test for trends. The proportion of
diagnostic AEEG in each group (sedation/GA or not and ASD or
not) was compared using exact conditional logistic regression and
calculation of an odds ratio. Synergy between administration of
sedation/GA and ASD was evaluated by conducting a multivariate
analysis that included both presence/absence of sedation/GA and
presence/absence of ASD in the statistical model. Tukey's post hoc
correction for multiple comparisons was used. The correlation
between episode frequency and time to first abnormality was
assessed using a Spearman correlation. Statistical significance was
defined as P < .05. Statistical tests were performed using SAS 9.3
(SAS Institute Inc, Cary, North Carolina).
3 | RESULTS
One hundred and eight dogs underwent AEEG for investigation of
paroxysmal episodes and were included in the study. Fifty-four differ-
ent breeds were represented. Females accounted for 45% of the pop-
ulation. Age ranged from 3 months to 15 years (average, 5.7 years;
median, 5 years). Comparison of signalment between groups is pro-
vided in Tables 1 and 2.
Sixty-three dogs did not receive sedation or GA whereas 45 dogs
received sedation or GA or both for electrode placement. Information
about ASDs was available for 107 dogs of which 62 were not receiv-
ing any ASDs at the time of AEEG recording and 45 were receiving at
least 1 ASD (Figure 1). The ASDs included phenobarbital, potassium
bromide, zonisamide, levetiracetam, imepitoin, gabapentin, diazepam,
and clorazepate used alone or in various combinations. Paroxysmal
episodes investigated were: suspected epileptic seizures, idiopathic
head tremors (head bobbing), compulsive tail chasing, myoclonus, epi-
sodic stiffness, compulsive tongue licking, fly biting, collapse episodes,
trance-like episodes, jaw chattering episodes, episodic drooling, epi-
sodic aggression, and possible rapid eye movement (REM) sleep
disorder.
Episode frequency ranged from at least 1 episode every minute
(minutely) to 1 episode per year on average (yearly). Most dogs in
both the sedation/GA and no sedation/GA groups had episodes that
occurred daily (Figure 2). No statistically significant difference in epi-
sode frequency distribution was identified between the 2 groups
(P = .08, Cochran-Armitage test). Similarly, most dogs experienced
daily episodes regardless of whether or not they were receiving ASD
and no significant difference in the episode frequency distribution
was found between the 2 groups (P = .4, Cochran-Armitage test,
Figure 3).
The AEEG recording was longer for dogs that received sedation/
GA compared to dogs that received neither (mean, 9.3 hours and
2.3 hours, respectively, P = 4 × 10−8, Mann-Whitney U test).
TABLE 1 Comparison of clinical characteristics between dogs that received sedation/general anesthesia (GA) for electrode placement and
dogs that received neither
Variable Sedation/GA No sedation/GA P value
Age (average, years) 6 5.3 .57
Sex 48% (22/45) female 43% (27/63) female .24
% of patient diagnosed with epileptic seizures 59% (13/22) 51% (22/43) .61
Duration of electroencephalography (mean, hours) 9.3 2.3 4.28 × 10−8
TABLE 2 Comparison of clinical characteristics between dogs that received at least 1 concurrent antiseizure drug (ASD) and dogs that
received none
Variable Antiseizure drug No ASD P value
Age (average, years) 5.7 5.8 .93
Sex 39% (17/44) female 48% (30/62) female .43
% of patient diagnosed with epileptic seizures 87% (20/23) 34% (14/41) .0001
Duration of electroencephalography (mean, hours) 5.9 4.7 .06
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Overall, diagnostic AEEG was obtained in 65/108 dogs (60.2%)
with 35 dogs confirmed to be experiencing epileptic seizures (53.8%)
and 30 experiencing other paroxysmal episodes (46.2%). For patients
confirmed to experience epileptic seizures based on the presence of
interictal or ictal epileptiform discharges on AEEG, diagnoses included
genetic epilepsy, suspected genetic epilepsy, epilepsy of unknown
cause, and structural epilepsy (meningoencephalitis of unknown etiol-
ogy, distemper encephalitis, neoplasia). For patients experiencing non-
epileptiform paroxysmal episodes, diagnoses included: compulsive
behaviors, Border Collie collapse, peripheral myoclonus, trance-like
syndrome of Bull Terriers, and REM sleep disorder. More dogs diag-
nosed with epileptic seizures on AEEG were concurrently receiving an
ASD compared to dogs diagnosed with non-epileptiform paroxysmal
discharges (58.82% versus 10%, respectively, P = 6 × 10−5, Fisher's
exact test).
To evaluate the effect of sedation and GA on the diagnostic capa-
bility of AEEG, we compared the proportion of diagnostic AEEG as
well as the time to reach a diagnosis (first abnormality or episode seen
on AEEG) between dogs that received sedation or GA and dogs that
received neither for electrode placement. A diagnosis was reached in
22/45 dogs that received sedation/GA (49%; 95% confidence interval
[CI], 34%-64%) and 43/63 dogs that received neither (68%; 95% CI,
55%-79%) representing an odds ratio (OR) of 2.25 (95% CI, 1.02-
5.00; P = .05).
Median time to first abnormality on AEEG was 28 minutes in our
sample and ranged from 1 to 1013 minutes. The overall proportion of
diagnostic AEEG over time is represented in Figure 4. For dogs that
received sedation/GA, the median was 39.5 minutes (95% CI, 2-249;
mean, 97 minutes; range: 1-1013 minutes) whereas it was 13 minutes
(95% CI, 1-277; mean, 47 minutes; range: 1-458 minutes) for dogs
that received neither, resulting in a difference of 26.5 minutes (P = .1).
We then evaluated the effect of concurrent ASD administration
of the diagnostic capability of AEEG in a similar fashion. A diagnosis
was reached in 23/45 dogs receiving at least 1 ASD (51%; 95% CI,
36%-66%) and in 41/62 dogs not receiving any ASD (66%; 95% CI,
53%-78%) resulting in an OR of 1.95 (95% CI, 0.89-4.3; P = .1).
Median time to first abnormality was 10 minutes for dogs receiv-
ing an ASD (95% CI, 1-159 minutes; mean, 51 minutes; range: 1-277
minutes) and 31 minutes for dogs not receiving any (95% CI,
2-458 minutes; mean, 73 minutes; range: 1-1013 minutes) resulting in
a difference of 21 minutes (P = .3).
To evaluate a potential synergistic effect of sedation/GA and con-
current ASD administration on proportion of diagnostic AEEG, we
performed a multivariate analysis by including both factors in our sta-
tistical model. No statistical difference was found between groups for
both proportion of diagnostic AEEG (P = .1) and time to first abnor-
mality (P = .8).
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F IGURE 1 Distribution of antiseizure drug (ASD) treatment in
dogs evaluated for paroxysmal episodes with
electroencephalography (EEG)
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F IGURE 2 Distribution of paroxysmal episode frequency
between dogs that received sedation/general anesthesia (GA) for
electrode placement (gray) and dogs that received neither (black).
Paroxysmal episode frequency was estimated from the medical
records for the event of interest
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F IGURE 3 Distribution of paroxysmal episode frequency
between dogs that received at least one concurrent antiseizure drug
(ASD; gray) and dogs that received none (black). Paroxysmal episode
frequency was estimated from the medical records for the event of
interest
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Finally, we evaluated the effect of episode frequency on the time
to first abnormality on AEEG. When grouping all of the dogs together,
a slight correlation was observed, with an increase in time to first
abnormality as the episode frequency decreased (r = 0.32; P = .01,
Spearman correlation). Subgroup analysis determined that this correla-
tion was stronger in the sedation/GA group (r = 0.70; P = .003, Spear-
man Correlation) whereas no correlation was observed for dogs that
received neither (r = 0.19; P = .2, Spearman correlation).
4 | DISCUSSION
Electroencephalography is rarely used clinically to differentiate epilep-
tic seizures from nonepileptic paroxysmal episodes in dogs, mostly
because of technical difficulties and lack of a standardized protocol.6-16
More specifically, the confounding factors that influence the diag-
nostic capability of electroencephalography are not known. Our study
evaluated the effect of sedation/GA for electrode placement and con-
current ASD treatment on the diagnostic capability of AEEG and did
not detect a strong association between the use of sedation/GA or
concurrent use of ASD and the diagnostic capability of AEEG. Sixty-
eight percent of dogs that did not receive sedation/GA had a diagnos-
tic AEEG compared to 49% of dogs that had received sedation/GA for
instrumentation (P = .05). To understand this result in a clinical con-
text, we calculated an absolute risk increase of 19% (95% CI, 0.78%-
38%). Therefore, the number of patients needed to harm is 5.16 (95%
CI, 2.63-128.33) which means that, on average, sedation/GA used for
electrode placement may prevent a diagnostic AEEG in 1 patient for
every 5 patients that receive sedation/GA. Although guidelines on
what is acceptable on that topic are not available, it could be accept-
able to use sedation/GA for electrode placement, especially if instru-
mentation for AEEG recording is challenging because of an
uncooperative patient. Moreover, the differences in time to first
abnormality observed were relatively small compared to the total
length of AEEG recording and may not be clinically relevant. Again, no
specific guidelines exist on recommended AEEG duration for veteri-
nary patients. However, in our study, median AEEG recording time for
dogs that received sedation/GA and did not receive a diagnosis (ie,
where the diagnosis potentially was missed because of sedation/GA)
was 4.75 hours with a mean of 9.01 hours (range, 0.83-32.5 hours).
Because the difference in time to first abnormality observed between
the 2 groups was only 26.5 minutes (P = .1), which is 10 times shorter
than the median recording time, this finding suggests that the differ-
ence may not be clinically relevant. These data suggest that GA or
sedation may be used with more confidence to facilitate AEEG elec-
trode placement provided that the AEEG recording extends beyond
recovery from sedation/GA. Similarly, starting an ASD before per-
forming an AEEG may not substantially impair our ability to differenti-
ate between epileptic seizures or other paroxysmal episodes. Here,
the absolute risk increase is 15.02% (95% CI, 3.75%-33.78%) which
gives a number of patients needed to harm of 6.66. Therefore, on
average, starting an ASD before AEEG recording may prevent
obtaining a diagnostic AEEG in 1 of every 7 patients. This estimate is
consistent with previous research findings because ASD do not
completely suppress interictal epileptiform discharges in patients that
still experience seizures and are not likey to suppress paroxysmal epi-
sodes that are not seizures, allowing the clinician to reach a diagnosis
with AEEG.27-29
Three dogs in our population received 4 to 6 ASD (1 dog received
4, 1 dog received 5, and 1 dog received 6) and therefore probably rep-
resent refractory epileptic patients because they continued to have
weekly episodes. The dog that received 6 ASD had interictal epilepti-
form discharges on AEEG, which allowed a diagnosis. The other 2
dogs did not have any epileptiform discharge nor did they experience
seizures during the recording and therefore were classified as having
a nondiagnostic AEEG.
These data support further questions about the potential use of
AEEG as a monitoring tool for epileptic patients. However,
levetiracetam previously has been shown to decrease ictal epilepti-
form discharges in a Rhodesian ridgebacks with juvenile myoclonic
epilepsy and absence seizures.30 Our study was not designed to eval-
uate the role of AEEG as a monitoring tool for epileptic patients
because dogs that were diagnosed with nonepileptic paroxysmal epi-
sodes using AEEG had been pre-emptively receiving ASD treatment
before AEEG recording. We also did not compare the decrease in ictal
or interictal epileptiform discharges in dogs by comparing paired
AEEG before and after an ASD because our goal was to evaluate the
effect of ASD on the overall diagnostic capability of AEEG. To answer
this specific question, a prospective study comparing the frequency of
ictal or interictal epileptiform discharges on AEEG before and after
starting an ASD in epileptic dogs would be warranted.
An interesting finding of our study was the time to first AEEG
abnormality observed, where this abnormality was either an episode
of interest on video or an epileptiform pattern on AEEG. Overall, 95%
of AEEG showed at least 1 abnormality within 277 minutes whereas a
30-minute recording showed at least 1 abnormality in only 35/65
dogs (53.4%). Other studies that have performed short-term
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F IGURE 4 Proportion of ambulatory wireless video
electroencephalography (AEEG) that have shown at least one
electrical abnormality or recorded one paroxysmal episode on video
over time
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electroencephalography (mean duration <45 minutes) while under
sedation/GA in dogs with suspected epileptic seizures have reported
diagnostic rates of 20 to 86%,8,11,15,31,32 which is consistent with our
findings. Although a previous study did not find any association
between AEEG diagnosis and duration of recording,10 this result may
have been because some recordings were continued even if a diagno-
sis was reached, thereby decreasing the association between AEEG
diagnosis and duration of AEEG recording. In our study, a plateau was
reached between 2 and 3 hours of recording, and 95% of dogs
showed at least 1 abnormality within 277 minutes of recording, which
argues for a minimum recording time of >4 hours (Figure 4). More-
over, this time to first abnormality is related to the episode frequency,
with a strong correlation for dogs receiving sedation/GA and an
increase in time to first abnormality as the episode frequency
decreases.
Limitations of our study are mainly a consequence of its retro-
spective nature. The AEEG recordings were not standardized across
dogs, which may have influenced capability to reach a diagnosis. The
number of electrodes, for example, varied among dogs and through-
out the recording because some were lost with time. It is unknown
however if the number of electrodes influences AEEG diagnostic
capability. Also, the time since the last episode was not taken into
account because it was not available in the majority of dogs and this
factor could influence the probability of witnessing an event during
AEEG recording. Other factors that may have influenced AEEG
recording and that were not investigated are skull shape and mastica-
tory muscle mass, which may decrease detection of the electrical sig-
nal originating from the cortex. Several sedative drugs and GA
protocols were used, and all dogs receiving either a sedative drug or
GA were placed in the sedation/GA group. Although different drugs
may have different pro- or antiepileptic properties, this grouping
allowed sufficient power for the study. Although the duration of
recording was not associated with the probability of obtaining a diag-
nostic EEG in another study, it could have been the case in our
study.10 However, the recordings were substantially longer in the
sedation/GA group whereas the proportion of diagnostic AEEG was
lower (49% versus 68%) albeit with a P-value of .05. Moreover, our
study did not include brain disorders that result in persistent behav-
ioral modifications such as certain metabolic encephalopathies
because we selected only patients with intermittent paroxysmal
episodes.
An inherent limitation to the study of epilepsy using AEEG is that
this test is neither sensitive nor specific for the diagnosis of paroxys-
mal disorders. Particularly for our study, false positives could have
influenced our results if more false positives occurred in 1 of our
groups. Although unknown in dogs, normal children can have waves
that resemble epileptiform discharges and therefore result in false
positives for a diagnosis of epilepsy.33 Moreover, the sensitivity and
specificity of AEEG has been evaluated at 63 and 95%, respectively,
in humans presented after 1 suspected seizure.34 It therefore is possi-
ble that some patients in our study showed AEEG patterns mistaken
for interictal epileptiform discharges and were misclassified as having
a diagnostic AEEG. Given the high specificity of AEEG in humans, the
probability of a false-positive AEEG likely is low in our study. The
specificity of AEEG has not been evaluated in dogs yet because no
normal dogs have been evaluated using awake AEEG. However, elec-
troencephalography recordings have been performed in normal dogs
under sedation/GA. One study reported that at least 1 epileptiform
discharge could be recorded during electroencephalography in 9/19
(47.37%) healthy beagle dogs undergoing sedation with med-
etomidine.32 However, no epileptiform discharges were recorded in
45 healthy dogs under GA or in 10 healthy beagles undergoing elec-
troencephalography under GA and activation procedures.11,35
Another study recorded some epileptiform discharges in 1/6 clinically
healthy Finnish Spitz under medetomidine sedation.31 The variability
in the rate of false positives observed among these different studies
may be associated with differences in the protocols for electroen-
cephalography recording or in the population of dogs studied in 1
study32 because it is higher than the false positive rate reported in
humans.34
Although we studied AEEG recordings from 108 dogs, our study
may lack power to statistically differentiate between the small differ-
ences in the proportions of diagnostic AEEG recordings found in our
study. A post hoc analysis indicated we could detect a proportion of
39.2% diagnostic AEEG in the sedation/GA group with a power of
80% and a risk of type I error (α) of .05, which is lower than the pro-
portion detected in our study. However, because the differences
found probably are not clinically relevant, statistically confirming
smaller differences by increasing sample size may not provide more
practically useful information.
The dogs were not randomized between groups which may have
introduced bias in our study. To evaluate for such bias, a prospective
study, ideally with AEEG recording before and after GA, should be
performed. Such a paired, prospective study also would allow quantifi-
cation of any decrease in diagnostic AEEG associated with sedation/
GA or ASD treatment because our study only investigated their role
as potential risk factors for not obtaining a diagnostic AEEG, which
does not seem to be the case in our study population.
No blinding of treatment group was performed while reviewing
the AEEG. Because the AEEG were reviewed with video synchroniza-
tion which was used for diagnosis, it would have been difficult to blind
the AEEG evaluators to treatment groups. The findings used to clas-
sify an AEEG as diagnostic or not were objective (ie, presence or
absence of epileptiform discharges or paroxysmal episode of interest,
time to first abnormality seen), but lack of blinding may have intro-
duced some bias.
Finally, we used the presence of interictal epileptiform discharges
as well as the recording of an episode of interest to classify an AEEG
as diagnostic. In theory, only recording an episode of interest can dif-
ferentiate between an epileptic seizure or a nonepileptic paroxysmal
event. In human medicine, interictal epileptiform discharges are very
specific for epileptic seizures.5 These findings have not yet been eval-
uated in dogs.
In conclusion, we did not identify a clinically relevant decrease in
the diagnostic capability of AEEG with the use of sedation/GA or con-
current ASD nor was sedation/GA or concurrent ASD associated with
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a clinically relevant increase in time to the first observed abnormality.
The findings suggest that using these protocols may be acceptable for
electrode placement before AEEG recording, provided that AEEG is
performed while dogs are awake and able to display the episode of
interest. The duration of recording probably should be >4 hours to
increase the chance of recording an episode of interest or epileptiform
discharges on the AEEG, but the required time is dependent on the
frequency of the episode of interest, especially if sedation or GA
is used.
ORCID
Thomas Parmentier https://orcid.org/0000-0002-8992-1476
Franziska Wielaender https://orcid.org/0000-0002-3113-5659
Andrea Fischer https://orcid.org/0000-0001-7094-1947
Fiona M. K. James https://orcid.org/0000-0003-4331-4993
REFERENCES
1. Packer R, Berendt M, Bhatti S, et al. Inter-observer agreement of
canine and feline paroxysmal event semiology and classification by
veterinary neurology specialists and non-specialists. BMC Vet Res.
2015;11(1):39. https://doi.org/10.1186/s12917-015-0356-2.
2. Kumar-Pelayo M, Oller-Cramsie M, Mihu N, Harden C. Utility of
video-EEG monitoring in a tertiary care epilepsy center. Epilepsy
Behav. 2013;28(3):501-503. https://doi.org/10.1016/j.yebeh.2013.
06.015.
3. Watemberg N, Tziperman B, Dabby R, Hasan M, Zehavi L, Lerman-
Sagie T. Adding video recording increases the diagnostic yield of rou-
tine electroencephalograms in children with frequent paroxysmal
events. Epilepsia. 2005;46(5):716-719. https://doi.org/10.1111/j.
1528-1167.2005.50004.x.
4. Nordli DR. Usefulness of video-EEG monitoring. Epilepsia. 2006;47
(s1):26-30. https://doi.org/10.1111/j.1528-1167.2006.00656.x.
5. Goodin Douglas S, Aminoff Michael J. Does the interictal EEG have a
role in the diagnosis of epilepsy? Lancet. 1984;323(8381):837-839.
https://doi.org/10.1016/S0140-6736(84)92281-5.
6. Pellegrino F. Canine electroencephalographic recording technique:
findings in normal and epileptic dogs. Clin Neurophysiol. 2004;115(2):
477-487. https://doi.org/10.1016/S1388-2457(03)00347-X.
7. Hasegawa D. Diagnostic techniques to detect the epileptogenic zone:
pathophysiological and presurgical analysis of epilepsy in dogs and
cats. Vet J. 2016;215:64-75. https://doi.org/10.1016/j.tvjl.2016.
03.005.
8. Berendt M, Høgenhaven H, Flagstad A, Dam M. Electroencephalogra-
phy in dogs with epilepsy: similarities between human and canine
findings. Acta Neurol Scand. 1999;99(5):276-283. https://doi.org/10.
1111/j.1600-0404.1999.tb00676.x.
9. Cauduro A, Dondi M, Favole P, Opreni M, Simonetto LA, Lorenzo V.
Artifacts during short-term Interictal electroencephalographic record-
ing in dogs. J Am Anim Hosp Assoc. 2017;53(2):80-89. https://doi.org/
10.5326/JAAHA-MS-6486.
10. James FMK, Cortez MA, Monteith G, et al. Diagnostic utility of wire-
less video-electroencephalography in unsedated dogs. J Vet Intern
Med. 2017;31(5):1469-1476. https://doi.org/10.1111/jvim.14789.
11. Jaggy A, Bernardini M. Idiopathic epilepsy in 125 dogs: a long-term
study. Clinical and electroencephalographic findings. J Small Anim
Pract. 1998;39(1):23-29. https://doi.org/10.1111/j.1748-5827.1998.
tb03665.x.
12. Steiss JE. A survey of current techniques in veterinary electro-
diagnostics: EEG, spinal evoked and brainstem auditory evoked
potential recording. Vet Res Commun. 1988;12(4–5):281-288. https://
doi.org/10.1007/BF00343246.
13. Tepper LC, Shores A. Electroencephalographic recordings in the
canine: effects of low dose medetomidine or dexmedetomidine
followed by atipamezole. Open J Vet Med. 2014;04(02):7-13. https://
doi.org/10.4236/ojvm.2014.42002.
14. Holliday TA, Williams DC. Interictal paroxysmal discharges in the
electroencephalograms of epileptic dogs. Clin Tech Small Anim Pract.
1998;13(3):132-143. https://doi.org/10.1016/S1096-2867(98)
80034-0.
15. Brauer C, Kästner SBR, Rohn K, Schenk HC, Tünsmeyer J, Tipold A.
Electroencephalographic recordings in dogs suffering from idiopathic
and symptomatic epilepsy: diagnostic value of interictal short time
EEG protocols supplemented by two activation techniques. Vet J.
2012;193(1):185-192. https://doi.org/10.1016/j.tvjl.2011.10.006.
16. Akos P, Thalhammer J, Leschnik M, Halász P. Electroencephalo-
graphic examination of epileptic dogs under propofol restraint. Acta
Vet Hung. 2012;60(3):309-324. https://doi.org/10.1556/AVet.
2012.026.
17. Cuff DE, Bush WW, Stecker MM, Williams DC. Use of continuous
electroencephalography for diagnosis and monitoring of treatment of
nonconvulsive status epilepticus in a cat. J Am Vet Med Assoc. 2014;
244(6):708-714. https://doi.org/10.2460/javma.244.6.708.
18. Granum LK, Bush WW, Williams DC, Stecker MM, Weaver CE,
Werre SR. Prevalence of electrographic seizure in dogs and cats
undergoing electroencephalography and clinical characteristics and
outcome for dogs and cats with and without electrographic seizure:
104 cases (2009–2015). J Am Vet Med Assoc. 2019;254(8):967-973.
https://doi.org/10.2460/javma.254.8.967.
19. Blades Golubovic S, Rossmeisl JH. Status epilepticus in dogs and cats,
part 1: etiopathogenesis, epidemiology, and diagnosis: status
epilepticus: etiopathogenesis and diagnosis. J Vet Emerg Crit Care.
2017;27(3):278-287. https://doi.org/10.1111/vec.12605.
20. Chaitanya G, Arivazhagan A, Sinha S, et al. Dexmedetomidine anes-
thesia enhances spike generation during intra-operative ele-
ctrocorticography: a promising adjunct for epilepsy surgery. Epilepsy
Res. 2015;109:65-71. https://doi.org/10.1016/j.eplepsyres.2014.
10.006.
21. Lee W-L, Hablitz JJ. Effect of APV and ketamine on epileptiform
activity in the CA1 and CA3 regions of the hippocampus. Epilepsy Res.
1990;6(2):87-94.
22. Meyer S, Shamdeen MG, Kegel B, et al. Effect of propofol on seizure-
like phenomena and electroencephalographic activity in children with
epilepsy vs children with learning difficulties. Anaesthesia. 2006;61(11):
1040-1047. https://doi.org/10.1111/j.1365-2044.2006.04782.x.
23. Zijlmans M, Huiskamp GM, Cremer OL, Ferrier CH, van Huffelen AC,
Leijten FSS. Epileptic high-frequency oscillations in intraoperative ele-
ctrocorticography: the effect of propofol. Epilepsia. 2012;53(10):
1799-1809. https://doi.org/10.1111/j.1528-1167.2012.03650.x.
24. Fredsø N, Sabers A, Toft N, Møller A, Berendt M. A single-blinded
phenobarbital-controlled trial of levetiracetam as mono-therapy in
dogs with newly diagnosed epilepsy. Vet J. 2016;208:44-49. https://
doi.org/10.1016/j.tvjl.2015.10.018.
25. Stabile F, van Dijk J, Barnett CR, De Risio L. Epileptic seizure fre-
quency and semiology in dogs with idiopathic epilepsy after initiation
of imepitoin or phenobarbital monotherapy. Vet J. 2019;249:53-57.
https://doi.org/10.1016/j.tvjl.2019.05.007.
26. St. Louis EK, Frey LC, Britton JW, et al. Electroencephalography (EEG):
An Introductory Text and Atlas of Normal and Abnormal Findings in
Adults, Children, and Infants. Chicago, IL: American Epilepsy Society;
2016 http://www.ncbi.nlm.nih.gov/books/NBK390354/. Accessed
September 27, 2019.
27. Libenson MH, Caravale B. Do antiepileptic drugs differ in suppressing
interictal epileptiform activity in children? Pediatr Neurol. 2001;24(3):
214-218. https://doi.org/10.1016/S0887-8994(00)00271-X.
28. Guida M, Iudice A, Bonanni E, Giorgi FS. Effects of antiepileptic drugs
on interictal epileptiform discharges in focal epilepsies: an update on
PARMENTIER ET AL. 1973
current evidence. Expert Rev Neurother. 2015;15(8):947-959. https://
doi.org/10.1586/14737175.2015.1065180.
29. Selvitelli MF, Walker LM, Schomer DL, Chang BS. The relationship of
interictal epileptiform discharges to clinical epilepsy severity: a study
of routine electroencephalograms and review of the literature. J Clin
Neurophysiol. 2010;27(2):87-92. https://doi.org/10.1097/WNP.
0b013e3181d64b1e.
30. Wielaender F, James FMK, Cortez MA, et al. Absence seizures as a
feature of juvenile myoclonic epilepsy in Rhodesian ridgeback dogs. J
Vet Intern Med. 2018;32(1):428-432. https://doi.org/10.1111/jvim.
14892.
31. Jeserevics J, Viitmaa R, Cizinauskas S, et al. Electroencephalography
findings in healthy and Finnish Spitz dogs with epilepsy: visual and
background quantitative analysis. J Vet Intern Med. 2007;21:1299-
1306.
32. Wrzosek M, Ives JR, Karczewski M, Dziadkowiak E, Gruszka E. The
relationship between epileptiform discharges and background activity
in the visual analysis of electroencephalographic examinations in dogs
with seizures of different etiologies. Vet J. 2017;222:41-51. https://
doi.org/10.1016/j.tvjl.2017.03.003.
33. Mizrahi EM. Avoiding the pitfalls of EEG interpretation in childhood
epilepsy. Epilepsia. 1996;37(s1):S41-S51. https://doi.org/10.1111/j.
1528-1157.1996.tb06021.x.
34. Geut I, Weenink S, Knottnerus ILH, van Putten MJAM. Detecting
interictal discharges in first seizure patients: ambulatory EEG or EEG
after sleep deprivation? Seizure. 2017;51:52-54. https://doi.org/10.
1016/j.seizure.2017.07.019.
35. Brauer C, Kästner SBR, Schenk HC, Tünsmeyer J, Tipold A. Electroen-
cephalographic recordings in dogs: prevention of muscle artifacts and
evaluation of two activation techniques in healthy individuals. Res Vet
Sci. 2011;90(2):306-311. https://doi.org/10.1016/j.rvsc.2010.06.004.
How to cite this article: Parmentier T, Monteith G,
Cortez MA, et al. Effect of prior general anesthesia or sedation
and antiseizure drugs on the diagnostic utility of wireless
video electroencephalography in dogs. J Vet Intern Med. 2020;
34:1967–1974. https://doi.org/10.1111/jvim.15856
1974 PARMENTIER ET AL.
